Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 11:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1153–1176 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Pain, Anxiety
Interventions: Synera; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Multiple Sclerosis, Magnetic Resonance Imaging, Biomarkers, Clinically Isolated Syndrome, Radiologically Isolated Syndrome
Interventions: Brain MRI; Diagnostic Test
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 30 Years
Enrollment: 300 participants
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Head and Neck Cancer, Squamous Cell Carcinoma of the Oral Cavity or Oropharynx, Head and Neck Neoplasms, Carcinoma of the Head and Neck
Interventions: Allovectin-7®; Genetic
Lead sponsor: Vical; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2002
U.S. locations: 10
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Tampa, Florida + 7 more

Conditions: Hidradenitis Suppurativa
Interventions: Topical roflumilast 0.3% foam; Drug
Lead sponsor: Tulane University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 4
States / cities: Covington, Louisiana • New Orleans, Louisiana

Conditions: Skin Lesion, Skin Abnormalities, Sebaceous Hyperplasia
Interventions: CellFX System, Intralesional Electrodesiccation; Device
Lead sponsor: Pulse Biosciences, Inc.; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 5
States / cities: Scottsdale, Arizona • Edina, Minnesota • Charlotte, North Carolina + 2 more

Conditions: Ankle Sprain
Interventions: Diclofenac epolamine, Placebo; Drug · Other
Lead sponsor: Actavis Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 658 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 31
States / cities: Birmingham, Alabama • Goodyear, Arizona • Carlsbad, California + 26 more

Conditions: Atrial Fibrillation (AF), Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma
Interventions: Not listed
Lead sponsor: Tina Baykaner; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 3
States / cities: Duarte, California • San Diego, California • Stanford, California

Conditions: Oral Candidiasis
Interventions: Acidophilus, Acidolphilus; Dietary Supplement
Lead sponsor: Summa Health System; Other
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Akron, Ohio

Conditions: Colon Cancer
Interventions: Inspection with Narrow-Band Imaging(NBI), Standard White Light; Procedure
Lead sponsor: Indiana University; Other
Eligibility: 50 Years to 85 Years
Enrollment: 898 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Head And Neck Cancer, Oropharynx Cancer
Interventions: Visual Examination, OraTest; Other · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 45 Years and older
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Healthy
Interventions: Tetrix; Device
Lead sponsor: Coria Laboratories, Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Aortic Arch Dissection, Aortic Arch Aneurysm
Interventions: GORE® TAG® Thoracic Branch Endoprosthesis; Device
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2036
U.S. locations: 24
States / cities: Scottsdale, Arizona • Los Angeles, California • Palo Alto, California + 19 more

Conditions: Postpartum Depression, Depression
Interventions: 17beta Estradiol, Placebos; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 20 Years to 45 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2016
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hepatocellular Carcinoma, Liver Metastases, Cutaneous or Subcutaneous Lymph Node, Liver Tumors
Interventions: Talimogene Laherparepvec, Pembrolizumab; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 9
States / cities: Scottsdale, Arizona • Santa Monica, California • Washington D.C., District of Columbia + 6 more

Conditions: Skin Lesion
Interventions: Photos; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Atherosclerosis, Angioplasty, Peripheral Arterial Disease
Interventions: Paclitaxel; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 80 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Post Operative Pain Management
Interventions: Scopolamine Patch (Transderm V); Drug
Lead sponsor: Alexander M Spiess, MD; Other
Eligibility: 18 Years to 55 Years
Enrollment: 74 participants
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Smoking
Interventions: Bupropion, Mecamylamine, Nicotine Patch; Drug
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 20 Years to 40 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2001
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Dental Caries
Interventions: Fluoride; Drug
Lead sponsor: Indiana Nanotech, LLC; Other
Eligibility: 13 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: PAD
Interventions: Stent Peripheral System; Device
Lead sponsor: EndoCore Lab s.r.l.; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Wyoming, Michigan

Conditions: Peripheral Arterial Disease, Cardiovascular Disease, Peripheral Vascular Disease
Interventions: Paclitaxel administration using the OPC; Other
Lead sponsor: Horizons International Peripheral Group; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 17
States / cities: Fairhope, Alabama • Jacksonville, Florida • Pensacola, Florida + 13 more

Conditions: Cigarette Smoking, Addiction, E Cig Use
Interventions: E cigarettes, Nicotine Replacement Therapy; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy
Interventions: ZTlido (Lidocaine Topical System) 1.8%, Salonpas (Lidocaine Patch 4%), Aspercreme (Lidocaine Patch 4%), IcyHot (Lidocaine 4% + Menthol 1% Patch); Drug
Lead sponsor: Scilex Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Dilworth, Minnesota

Conditions: Acute Migraine
Interventions: ZP-Zolmitriptan, Placebo; Drug
Lead sponsor: Zosano Pharma Corporation; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 365 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 36
States / cities: Glendale, Arizona • Carlsbad, California • Huntington Beach, California + 32 more

Search by objective public record fields.

Study of Use of Synera for Pain During Local Skin Infiltration With Lidocaine Before Epidural Placement

Risk Factors in Early Multiple Sclerosis

Phase II Trial of Allovectin-7® for Head and Neck Cancer

A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa

Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions

Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain

Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy

Acidophilus for the Treatment and Prevention of Oral Candidiasis in Patients Undergoing Radiation Therapy

Narrow-Band Imaging Versus Standard White Light for the Detection of Serrated Lesions in the Proximal Colon

OraTest in Combination With Visual Examination and Visual Examination Alone

Evaluation of Tetrix Cream in the Healing of Injured Skin in Subjects With Contact Dermatitis

GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study

Clinical Trial of Estrogen for Postpartum Depression

Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611

Smartphone Application to Detect Skin Lesions

Local Paclitaxel Delivery for SFA Disease

A Novel Usage of Transdermal Scopolamine in Reducing Narcotic Usage in Outpatient Hand Surgery

Combinations of Pharmacologic Smoking Cessation Treatments

Development and Validation of a Multi-Mineral Fluoride Mouthrinse

SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients

The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee

Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder

Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing Patches

Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine